1 false false false false false false false false false false true false false false false true true No description of principal activity 2023-01-17 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14599378 2023-01-17 2024-01-31 14599378 2024-01-31 14599378 2023-01-16 14599378 bus:Director1 2023-01-17 2024-01-31 14599378 core:WithinOneYear 2024-01-31 14599378 bus:Micro-entities 2023-01-17 2024-01-31 14599378 bus:AuditExempt-NoAccountantsReport 2023-01-17 2024-01-31 14599378 bus:SmallCompaniesRegimeForAccounts 2023-01-17 2024-01-31 14599378 bus:PrivateLimitedCompanyLtd 2023-01-17 2024-01-31 14599378 bus:FullAccounts 2023-01-17 2024-01-31
COMPANY REGISTRATION NUMBER: 14599378
Pharmanuel Limited
Filleted Unaudited Financial Statements
31 January 2024
Pharmanuel Limited
Statement of Financial Position
31 January 2024
Period from
17 Jan 23 to
31 Jan 24
£
£
Current assets
2,361
Prepayments and accrued income
14,111
--------
16,472
Creditors: amounts falling due within one year
17,161
--------
Net current liabilities
689
----
Total assets less current liabilities
( 689)
Accruals and deferred income
480
-------
(1,169)
-------
Capital and reserves
( 1,169)
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the period amounted to 1 .
2. Director's advances, credits and guarantees
During the year there were no director's advances, credits and guarantees.
For the period ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 16 October 2024 , and are signed on behalf of the board by:
MR M Mestre Valdes
Director
Company registration number: 14599378
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 392 Chanterlands Avenue, Hull, HU5 4ED, England.